← Back to Search

Vibration-based Device

Evaluation of Vibration-based Wearable Upper Limb Rehabilitation Device

N/A
Waitlist Available
Led By Hongwu Wang, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline cahai-7 at 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

The investigators will perform a pilot 4-week at home study with 48 individuals with stroke and 10 therapists working with stroke patients to examine the feasibility and effect of a wearable focal muscle vibration device on upper limb strength and function.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline cahai-7 at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline cahai-7 at 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in arm and hand function as assessed by CAHAI-7
Changes in grip strength
Changes in self-reported functional upper extremity performance as assessed by MAL
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: low frequency low amplitudeExperimental Treatment1 Intervention
The vibration frequency is 60 Hz and amplitude is 0.2 mm
Group II: low frequency high amplitudeExperimental Treatment1 Intervention
The vibration frequency is 60 Hz and amplitude is 2 mm
Group III: high frequency low amplitudeExperimental Treatment1 Intervention
The vibration frequency is 120 Hz and amplitude is 0.2 mm
Group IV: high frequency high amplitudeExperimental Treatment1 Intervention
The vibration frequency is 120 Hz and amplitude is 2 mm

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
474 Previous Clinical Trials
93,687 Total Patients Enrolled
4 Trials studying Stroke
174 Patients Enrolled for Stroke
Hongwu Wang, PhDPrincipal InvestigatorUniversity of Oklahoma
2 Previous Clinical Trials
15 Total Patients Enrolled
~1 spots leftby Jan 2026